Dorota Krochmalczyk

859 total citations
15 papers, 111 citations indexed

About

Dorota Krochmalczyk is a scholar working on Genetics, Rheumatology and Oncology. According to data from OpenAlex, Dorota Krochmalczyk has authored 15 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Rheumatology and 5 papers in Oncology. Recurrent topics in Dorota Krochmalczyk's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (8 papers) and Lymphoma Diagnosis and Treatment (4 papers). Dorota Krochmalczyk is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (8 papers) and Lymphoma Diagnosis and Treatment (4 papers). Dorota Krochmalczyk collaborates with scholars based in Poland, Denmark and Austria. Dorota Krochmalczyk's co-authors include Tomasz Sacha, Niels Pallisgaard, Sabrina Cordua, Pencho Georgiev, Liana Gercheva, Christoph Klade, Kurt Krejcy, Jiřı́ Mayer, Petr Ďulíček and Árpád Illés and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Hematology.

In The Last Decade

Dorota Krochmalczyk

15 papers receiving 110 citations

Peers

Dorota Krochmalczyk
Giuseppe Auteri Italy
Juliana Schwaab Germany
Roman Hakl Czechia
Daniela Bartoletti Italy
Ajay Kundra United States
Teresa Ferró Spain
Craig A. Kovitz United States
Elisabetta Colaci Italy
Chiara Pavoni Italy
G Marzocchi Italy
Giuseppe Auteri Italy
Dorota Krochmalczyk
Citations per year, relative to Dorota Krochmalczyk Dorota Krochmalczyk (= 1×) peers Giuseppe Auteri

Countries citing papers authored by Dorota Krochmalczyk

Since Specialization
Citations

This map shows the geographic impact of Dorota Krochmalczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorota Krochmalczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorota Krochmalczyk more than expected).

Fields of papers citing papers by Dorota Krochmalczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorota Krochmalczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorota Krochmalczyk. The network helps show where Dorota Krochmalczyk may publish in the future.

Co-authorship network of co-authors of Dorota Krochmalczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Dorota Krochmalczyk. A scholar is included among the top collaborators of Dorota Krochmalczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorota Krochmalczyk. Dorota Krochmalczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Kiladjian, Jean‐Jacques, Christoph Klade, Pencho Georgiev, et al.. (2022). Efficacy and Safety of Long-Term Ropeginterferon Alfa-2b Treatment in Patients with Low-Risk and High-Risk Polycythemia Vera (PV). Blood. 140(Supplement 1). 9663–9664. 3 indexed citations
3.
4.
Gisslinger, Heinz, Christoph Klade, Pencho Georgiev, et al.. (2020). Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: 5-Year Results from a Randomized Controlled Study and Its Extension. Blood. 136(Supplement 1). 33–33. 10 indexed citations
5.
Gisslinger, Heinz, Christoph Klade, Pencho Georgiev, et al.. (2020). Ropeginterferon Alfa‐2b: Efficacy and Safety in Different Age Groups. HemaSphere. 4(6). e485–e485. 4 indexed citations
6.
Gisslinger, Heinz, Christoph Klade, Pencho Georgiev, et al.. (2019). Ropeginterferon Alfa-2b versus Standard Therapy for Polycythaemia Vera; a Randomised, Controlled, Phase III Trial. SSRN Electronic Journal. 5 indexed citations
7.
Warzocha, Krzysztof, Wojciech Homenda, Andrzej Pluta, et al.. (2019). Ruksolitynib w terapii chorych na mielofibrozę — pytania i odpowiedzi. Via Medica Journals. 9(4). 269–284. 1 indexed citations
8.
9.
Kiladjian, Jean‐Jacques, Christoph Klade, Pencho Georgiev, et al.. (2019). Thromboembolic Risk Reduction and High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: Results from a Randomized Controlled Study. Blood. 134(Supplement_1). 553–553. 4 indexed citations
10.
Pallisgaard, Niels, et al.. (2018). A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs. Annals of Hematology. 97(12). 2299–2308. 49 indexed citations
11.
Gisslinger, Heinz, Christoph Klade, Pencho Georgiev, et al.. (2018). Evidence for Superior Efficacy and Disease Modification after Three Years of Prospective Randomized Controlled Treatment of Polycythemia Vera Patients with Ropeginterferon Alfa-2b Vs. HU/BAT. Blood. 132(Supplement 1). 579–579. 14 indexed citations
12.
Jurczak, Wojciech, et al.. (2012). [Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma].. PubMed. 69(5). 171–5. 1 indexed citations
13.
Jurczak, Wojciech, Agnieszka Giza, Dorota Krochmalczyk, et al.. (2009). Survival benefit of post induction consolidation therapy in MCL (mantle cell lymphoma): A Polish Lymphoma Research Group (PLRG) retrospective multicenter analysis. Journal of Clinical Oncology. 27(15_suppl). e19510–e19510. 3 indexed citations
14.
Jurczak, Wojciech, Agnieszka Giza, Dorota Krochmalczyk, et al.. (2005). Consolidation of Chemotherapy Response in Mantle Cell Lymphoma (MCL) Patients with 90Y-Ibritumomab Tiuxetan (90Y-Zevalin) Radioimmunotherapy (RIT).. Blood. 106(11). 2453–2453. 3 indexed citations
15.
Jurczak, Wojciech, Zbigniew Rudzki, Dorota Krochmalczyk, et al.. (2004). Impaired Clonogenic Capacity Contributes to Bone Marrow Hypoplasia and Late Hematological Recovery after Zevalin in the Low-Grade NHL Patients.. Blood. 104(11). 4610–4610. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Auteri Breakdown of academic impact, for papers by Juliana Schwaab Breakdown of academic impact, for papers by Roman Hakl Breakdown of academic impact, for papers by Daniela Bartoletti Breakdown of academic impact, for papers by Ajay Kundra Breakdown of academic impact, for papers by Teresa Ferró Breakdown of academic impact, for papers by Craig A. Kovitz Breakdown of academic impact, for papers by Elisabetta Colaci Breakdown of academic impact, for papers by Chiara Pavoni Breakdown of academic impact, for papers by G Marzocchi
Rankless by CCL
2026